Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer.
By: Xiongyan Wu, Xuehua Chen, Quan Zhou, Pu Li, Beiqin Yu, Jianfang Li, Ying Qu, Jun Yan, Yingyan Yu, Min Yan, Zhenggang Zhu, Bingya Liu, Liping Su

Shanghai Key Laboratory of Gastric Neoplasms, Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, People's Republic of China.
2012-11-29; doi: 10.1016/j.canlet.2013.02.002
Abstract

Cancer-associated fibroblasts (CAFs), as the activated fibroblasts in tumor stroma, are important modifiers of tumor progression. However, the mechanisms underlying stromal fibroblast activation and their promotion of tumor growth remain largely unknown in gastric cancer. Here, we show that normal fibroblasts (NFs) from non-cancerous regions of gastric cancer exhibit the traits of CAFs when grown together with gastric cancer cells in vivo. Activation of NFs can be induced by co-culture with gastric cancer cells, while deprivation of hepatocyte growth factor (HGF) using a neutralizing antibody inhibits the activation of NFs. Moreover, we identify HGF as an important factor from CAFs that acts in a paracrine manner to promote tumorigenesis in vitro and in vivo. Taken together, these results suggest that HGF may play a pivotal role in the regulatory circuit between gastric cancer cells and stromal fibroblasts, and neutralization of HGF inhibits both activation and tumor-promoting properties of CAFs.



Copyright © 2013. Published by Elsevier Ireland Ltd.

PMID:23402812






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements